2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
19
Neoplasms
11
Polycystic Ovary Syndrome
9
Neoplasm Metastasis
4
Multiple Myeloma
4
Melanoma
4
Vomiting
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Leiomyoma
3
Head and Neck Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Obesity
2
Nausea
2
Myofibroma
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Leukemia
2
Insulin Resistance
2
Inflammation
2
Infertility, Female
2
Interventions
Cyclophosphamide
35
Temozolomide
33
Filgrastim
26
Etoposide
26
Carboplatin
25
Vincristine
22
Cisplatin
22
Radiotherapy
20
Magnetic Resonance Spectroscopy
18
Thiotepa
14
Irinotecan
13
Granulocyte Colony-Stimulating Factor
12
Peripheral Blood Stem Cell Transplantation
11
Lomustine
11
Specimen Handling
9
Radiation
9
Melphalan
9
etoposide phosphate
8
Topotecan
8
Methotrexate
8
X-Rays
7
Platinum
7
Phantoms, Imaging
7
sonidegib
6
Biopsy
6
1,2-diaminocyclohexaneplatinum II citrate
6
sargramostim
5
palbociclib
5
Nuclear Medicine Department, Hospital
5
HhAntag691
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Tablets
×
Clear all
NCT05230758
2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3
Recruiting
140 enrolled